10-71351676-G-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_018344.6(SLC29A3):​c.498G>C​(p.Ala166Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00368 in 1,614,066 control chromosomes in the GnomAD database, including 117 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A166A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0054 ( 20 hom., cov: 32)
Exomes 𝑓: 0.0035 ( 97 hom. )

Consequence

SLC29A3
NM_018344.6 synonymous

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.47

Publications

2 publications found
Variant links:
Genes affected
SLC29A3 (HGNC:23096): (solute carrier family 29 member 3) This gene encodes a nucleoside transporter. The encoded protein plays a role in cellular uptake of nucleosides, nucleobases, and their related analogs. Mutations in this gene have been associated with H syndrome, which is characterized by cutaneous hyperpigmentation and hypertrichosis, hepatosplenomegaly, heart anomalies, and hypogonadism. A related disorder, PHID (pigmented hypertrichosis with insulin-dependent diabetes mellitus), has also been associated with mutations at this locus. Alternatively spliced transcript variants have been described.[provided by RefSeq, Mar 2010]
SLC29A3 Gene-Disease associations (from GenCC):
  • H syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • dysosteosclerosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 10-71351676-G-C is Benign according to our data. Variant chr10-71351676-G-C is described in ClinVar as Benign. ClinVar VariationId is 300361.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.47 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00542 (825/152234) while in subpopulation SAS AF = 0.0211 (102/4826). AF 95% confidence interval is 0.0178. There are 20 homozygotes in GnomAd4. There are 589 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 20 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC29A3NM_018344.6 linkc.498G>C p.Ala166Ala synonymous_variant Exon 4 of 6 ENST00000373189.6 NP_060814.4 Q9BZD2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC29A3ENST00000373189.6 linkc.498G>C p.Ala166Ala synonymous_variant Exon 4 of 6 1 NM_018344.6 ENSP00000362285.5 Q9BZD2-1

Frequencies

GnomAD3 genomes
AF:
0.00540
AC:
822
AN:
152116
Hom.:
20
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0133
Gnomad SAS
AF:
0.0213
Gnomad FIN
AF:
0.0526
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00107
Gnomad OTH
AF:
0.00431
GnomAD2 exomes
AF:
0.00804
AC:
2021
AN:
251482
AF XY:
0.00853
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0129
Gnomad FIN exome
AF:
0.0498
Gnomad NFE exome
AF:
0.00158
Gnomad OTH exome
AF:
0.00717
GnomAD4 exome
AF:
0.00349
AC:
5109
AN:
1461832
Hom.:
97
Cov.:
35
AF XY:
0.00391
AC XY:
2841
AN XY:
727220
show subpopulations
African (AFR)
AF:
0.0000597
AC:
2
AN:
33480
American (AMR)
AF:
0.000201
AC:
9
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.0108
AC:
428
AN:
39698
South Asian (SAS)
AF:
0.0152
AC:
1315
AN:
86256
European-Finnish (FIN)
AF:
0.0457
AC:
2439
AN:
53418
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5768
European-Non Finnish (NFE)
AF:
0.000526
AC:
585
AN:
1111960
Other (OTH)
AF:
0.00536
AC:
324
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
302
604
906
1208
1510
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00542
AC:
825
AN:
152234
Hom.:
20
Cov.:
32
AF XY:
0.00791
AC XY:
589
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.0000482
AC:
2
AN:
41536
American (AMR)
AF:
0.000588
AC:
9
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.0135
AC:
70
AN:
5182
South Asian (SAS)
AF:
0.0211
AC:
102
AN:
4826
European-Finnish (FIN)
AF:
0.0526
AC:
557
AN:
10596
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00107
AC:
73
AN:
68012
Other (OTH)
AF:
0.00568
AC:
12
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
43
86
128
171
214
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00201
Hom.:
1
Bravo
AF:
0.00117
Asia WGS
AF:
0.0290
AC:
99
AN:
3478
EpiCase
AF:
0.000327
EpiControl
AF:
0.000593

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

H syndrome Benign:2
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.11
DANN
Benign
0.42
PhyloP100
-1.5

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150879861; hg19: chr10-73111433; API